Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAN2A1-DT (MAN2A1 divergent transcript) is a non-coding RNA transcript arising from the *MAN2A1* gene region, likely transcribed from the opposite DNA strand in a bidirectional promoter context[1][5]. Divergent transcripts (often classified as long non-coding RNAs) are frequently observed from active promoters and may play regulatory roles in gene expression, though most have not been functionally characterized[5]. There is no evidence that MAN2A1-DT itself encodes a functional protein or serves as a validated molecular target for drugs or therapeutic intervention. If you intended the protein-coding enzyme **alpha-mannosidase 2** (encoded by *MAN2A1*), that is a functionally distinct entity and should be queried as “Mannosidase alpha class 2A member 1 (MAN2A1)” instead[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAN2A1 divergent transcript (MAN2A1-DT).